An Interview with Gerd Maass, VP for R&D at Roche Pharmaceuticals: Chapter 2 - Companion Diagnostics
In this section on companion diagnostics, Gerd Maass of Roche explains how CDx can help us to administer the right drug at the right time in the right dose to the right patient. He acknowledges the fact CDx is known to be costly and difficult to implement and utilise effectively and outlines the main problems and challenges. Maass also sets out the vital stages in translating biomarkers from the laboratory to the clinic – and the best ways of successfully validating them.
Finally, he reports on some innovative methods of using companion diagnostics to advance drug development and improve efficacy. Missed part one? An Interview with Gerd Maass, VP for R&D at Roche Pharmaceuticals: Chapter 1 - DNA Sequencing
Have Your Say
Rate this feature and give us your feedback in the comments section below
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.